Álvarez-Román, M. T., Cuervo-Arango, I., Pérez-Santamarina, R., Poveda, J. L., Romero, J. A., Santamaría, A., Trillo-Mata, J. L., Tort, M. and Badia, X. (2019) “Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis”, Global and Regional Health Technology Assessment, 6(1). doi: 10.33393/grhta.2019.452.